Spots Global Cancer Trial Database for head neck cancer
Every month we try and update this database with for head neck cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer | NCT05838729 | Head Neck Cance... Intratumoral In... | RiMO-301 | 18 Years - | Coordination Pharmaceuticals, Inc. | |
| Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer | NCT02075385 | Head Neck Cance... Swallowing Diso... | pre, during and... | 18 Years - | Barretos Cancer Hospital | |
| Sarcopenia in Head and Neck Cancer Patients Treated With Curative Hadrontherapy | NCT06207708 | Head and Neck C... | questionnaires ... blood biomarker... | 18 Years - | CNAO National Center of Oncological Hadrontherapy | |
| Pharyngocise Dose Response Study | NCT01279837 | Dysphagia | Pharyngocise | 21 Years - 90 Years | University of Florida | |
| Electrochemotherapy on Head and Neck Cancer | NCT02549742 | Head Neck Cance... | Electrochemothe... Cliniporator Bleomycin | 18 Years - | Rigshospitalet, Denmark | |
| Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors | NCT01951664 | Head Neck Cance... | Baseline Study ... Yoga Evaluation Yoga Program Yoga Practice P... Study Assessmen... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients | NCT04858269 | Head Neck Cance... Metastatic Squa... Oral Cavity Squ... Oropharynx Squa... Hypopharynx Squ... Larynx Squamous... | Pembrolizumab Carboplatin Paclitaxel | 18 Years - | Wake Forest University Health Sciences | |
| Sarcopenia in Head and Neck Cancer Patients Treated With Curative Hadrontherapy | NCT06207708 | Head and Neck C... | questionnaires ... blood biomarker... | 18 Years - | CNAO National Center of Oncological Hadrontherapy | |
| Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer | NCT04566367 | Head Neck Cance... Esophageal Canc... Gastrostomy | blue laser imag... | 18 Years - | Johann Wolfgang Goethe University Hospital | |
| Swallowing Intervention During Radiochemotherapy on Head and Neck Cancer | NCT02075385 | Head Neck Cance... Swallowing Diso... | pre, during and... | 18 Years - | Barretos Cancer Hospital | |
| Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients. | NCT03747562 | Head Neck Cance... Radiation Neuro... Pain, Neuropath... | Gabapentin Placebo | 18 Years - | University Hospital, Ghent | |
| A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | NCT02521870 | Metastatic Mela... Head Neck Cance... | SD-101(1) Pembrolizumab SD-101(2) Pembrolizumab SD-101(3) Pembrolizumab | 18 Years - | Dynavax Technologies Corporation | |
| Newer Therapeutic Targets in Head and Neck Cancers | NCT05382585 | Head Neck Cance... Oral Cancer | Next generation... | 18 Years - 100 Years | Banaras Hindu University | |
| A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma | NCT02521870 | Metastatic Mela... Head Neck Cance... | SD-101(1) Pembrolizumab SD-101(2) Pembrolizumab SD-101(3) Pembrolizumab | 18 Years - | Dynavax Technologies Corporation | |
| A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors | NCT05572684 | Advanced or Met... Microsatellite ... Microsatellite ... Microsatellite ... Ovarian Cancer Gastric Cancer Colo-rectal Can... Esophageal Canc... Endometrial Can... Head Neck Cance... Cervical Cancer Lung Cancer | NC410 pembrolizumab | 18 Years - | NextCure, Inc. | |
| Prosthetic Rehabilitation and Its Influence on Masticatory Performance and QoL in Patients Treated for HNC | NCT06124222 | Quality of Life Objective Masti... Subjective Mast... Oral Health | Prosthetic oral... | 18 Years - | University of Barcelona | |
| Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer | NCT05838729 | Head Neck Cance... Intratumoral In... | RiMO-301 | 18 Years - | Coordination Pharmaceuticals, Inc. | |
| Prosthetic Rehabilitation and Its Influence on Masticatory Performance and QoL in Patients Treated for HNC | NCT06124222 | Quality of Life Objective Masti... Subjective Mast... Oral Health | Prosthetic oral... | 18 Years - | University of Barcelona | |
| Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC | NCT03572829 | Vomiting Nausea Post Che... Head Neck Cance... | Aprepitant | 18 Years - 80 Years | ChineseAMS | |
| Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer | NCT03832686 | Head Neck Cance... | Virtual Coach | 18 Years - | Stanford University | |
| Investigation of Two Swallowing Therapy Models During Radiation Therapy for Head and Neck Cancer | NCT03832686 | Head Neck Cance... | Virtual Coach | 18 Years - | Stanford University | |
| Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer Survivors | NCT01951664 | Head Neck Cance... | Baseline Study ... Yoga Evaluation Yoga Program Yoga Practice P... Study Assessmen... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma | NCT00198328 | Head Neck Cance... | Medpulser Elect... Surgical Excisi... | 18 Years - | Inovio Pharmaceuticals | |
| Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer | NCT05838729 | Head Neck Cance... Intratumoral In... | RiMO-301 | 18 Years - | Coordination Pharmaceuticals, Inc. | |
| Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection | NCT02268344 | Shoulder Pain Head Neck Cance... | Grass SD9 Stimu... | 18 Years - 55 Years | University of Alberta | |
| Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer | NCT04566367 | Head Neck Cance... Esophageal Canc... Gastrostomy | blue laser imag... | 18 Years - | Johann Wolfgang Goethe University Hospital | |
| First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients | NCT04858269 | Head Neck Cance... Metastatic Squa... Oral Cavity Squ... Oropharynx Squa... Hypopharynx Squ... Larynx Squamous... | Pembrolizumab Carboplatin Paclitaxel | 18 Years - | Wake Forest University Health Sciences | |
| Aprepitant for Nause and Vomiting Induced by Chemoradiotherapy in HNSCC | NCT03572829 | Vomiting Nausea Post Che... Head Neck Cance... | Aprepitant | 18 Years - 80 Years | ChineseAMS | |
| Brief Intraoperative Electrical Stimulation for Prevention of Shoulder Dysfunction After Oncologic Neck Dissection | NCT02268344 | Shoulder Pain Head Neck Cance... | Grass SD9 Stimu... | 18 Years - 55 Years | University of Alberta | |
| First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients | NCT04858269 | Head Neck Cance... Metastatic Squa... Oral Cavity Squ... Oropharynx Squa... Hypopharynx Squ... Larynx Squamous... | Pembrolizumab Carboplatin Paclitaxel | 18 Years - | Wake Forest University Health Sciences | |
| Sentinel. Ambulatory. Oral Cavity. Oropharynx (S.A.C.O) | NCT03545256 | Cancer T1-N0 or... | outpatient surg... | 18 Years - | University Hospital, Montpellier | |
| Prosthetic Rehabilitation and Its Influence on Masticatory Performance and QoL in Patients Treated for HNC | NCT06124222 | Quality of Life Objective Masti... Subjective Mast... Oral Health | Prosthetic oral... | 18 Years - | University of Barcelona | |
| Pharyngocise Dose Response Study | NCT01279837 | Dysphagia | Pharyngocise | 21 Years - 90 Years | University of Florida |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
